Citazione APA

Viswabandya, A., Shah, S., Mukhopadhyay, A., Nagarkar, R. V., Batra, S. S., Lopez-Lazaro, L., . . . Srivastava, A. (2019). Randomized, Double-Blind, Pharmacokinetic Equivalence Trial Comparing DRL-Rituximab With MabThera in Patients With Diffuse Large B-Cell Lymphoma. J Glob Oncol.

Stile di citazione Chicago

Viswabandya, Auro, Sandip Shah, Asis Mukhopadhyay, Rajnish Vasant Nagarkar, Sonica Sachdeva Batra, Luis Lopez-Lazaro, Suresh Kankanwadi, e Alok Srivastava. "Randomized, Double-Blind, Pharmacokinetic Equivalence Trial Comparing DRL-Rituximab With MabThera in Patients With Diffuse Large B-Cell Lymphoma." J Glob Oncol 2019.

Citazione MLA

Viswabandya, Auro, et al. "Randomized, Double-Blind, Pharmacokinetic Equivalence Trial Comparing DRL-Rituximab With MabThera in Patients With Diffuse Large B-Cell Lymphoma." J Glob Oncol 2019.

Attenzione: Queste citazioni potrebbero non essere precise al 100%.